Davis Todd C bought LGND
March 25, 2024 · Form 4 insider transaction
Davis Todd C bought 7,448 shares of Ligand Pharmaceuticals Incorporated at $46.20 per share, a transaction worth $344.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,448
Price
$46.20
Total value
$344.1K
InsiderDavis Todd C
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 25, 2024
Filing dateMarch 27, 2024
Shares owned after111,593
OwnershipDirect
10b5-1 planNo
AmendedNo